The exceptionally large-scale chikungunya outbreak that struck Reunion Island in 2005-2006 raised numerous yet-unresolved issues for occupational medicine professionals such as massive use of insecticides and recognition of occupational diseases.
The chikungunya outbreak on Reunion Island in 2005-2006 was followed by a high incidence of persistent arthralgia. A small group of patients developed chronic, sometimes destructive, post-chikungunya inflammatory rheumatism presenting as rheumatoid polyarthritis or spondylarthritis that required disease-modifying antirheumatic drugs such as methotrexate. We describe two patients under this treatment confronted with financial health insurance issues due to the lack of administrative recognition of post-chikungunya rheumatism as a long-term affliction or an occupational disease.
L'affection a virus chikungunya qui a sevi a l'Ile de la Reunion de mai 2005 a fin 2006, a atteint 30 % de la population (plus de 250 000 personnes). Le retentissement precoce majeur clinique a permis de mieux decrire la phase aigue de la maladie. L'evolution est generalement lentement favorable chez un grand nombre de patients avec, sur plusieurs mois, l'expression de manifestations rhumatologiques, interrogeant sur plusieurs plans les praticiens quant a: i) la responsabilite de l'infection a virus chikungunya dans l'expression des manifestations douloureuses, ii) les therapeutiques a proposer, iii) la possibilite d'enrayer l'evolution chronique. L'observation de deux cohortes de patients a la Reunion tente d'apporter une reponse a la comprehension et a l'amelioration de la prise en charge des manifestations chroniques « post-chikungunya ». L'observation de 360 patients souffrant de manifestations douloureuses post-infection a virus chikungunya fait ressortir le risque majore de developpement d'une polyarthrite inflammatoire lorsque l'atteinte aigue initiale dure plus de 3 semaines avec la proposition pour ces patients d'une evaluation rhumatologique a 3 mois pour traitement par immunosupresseur (methotrexate).
Chronic arthritis following chikungunya infection has no specific treatment. Studies on mice have confirmed involvement of fibroblasts and myoblasts as target cells replicating the virus and shown that macrophages play a key role in the innate immune response involving multiple cytokines and chimiokines. Paradoxically, TH1 and TH2 cytokine levels do not increase significantly during the acute and chronic phases, with the exception of interferon-gamma and IL12 that rise dramatically during the acute phase. The level of IL12 returns to normal in patients who recover. In contrast, patients who develop chronic arthritis show persistently high IL12 levels along with IFN-alpha within PBMC. Histologic examination of synovia reveals joint inflammation due to macrophages containing viral material. Metallo-protease (MMP2) also contributes to tissue damage. Chikungunya virus leads to apoptosis by both the intrinsic and extrinsic pathways.
UNLABELLED In 2005-2006, an unexpected, massive outbreak of chikungunya occurred on Reunion Island, a French overseas territory in the Indian Ocean. This arboviral infection transmitted by a mosquito of the Aedes genus is usually benign. A surprising feature of the Reunion Island epidemic was the occurrence of rare severe forms involving adults as well as children. OBJECTIVES The purpose of this report is to describe severe forms of chikungunya observed in children hospitalized in a pediatric intensive care unit. PATIENTS AND METHODS This retrospective single-center study was conducted from January 1st to April 30th, 2006. Children between 1 month and 15 years admitted to the pediatric intensive care unit with proven chikungunya infection were included. RESULTS A total of 9 children were included. The main manifestations were extensive skin blisters in 5 cases, neurological symptoms (encephalopathy) in 4, cardiac complications (myocarditis, hemodynamic disorders) in 5 and bleeding in 1. Two children died. The causes of death were circulatory failure associated with coma and massive hemorrhage in one case and post-infectious encephalitis in the other. Three survivors present long-term neurologic or dermatologic sequels. DISCUSSION Severe cases of chikungunya in children provide a stark reminder of the cardiac and neurological tropism of the virus and its hemorrhagic forms with high potential mortality and morbidity. These cases underline the need for personal protection measures and for research to develop specific antiviral therapy and vaccines to prevent potentially lethal forms of the disease.
After a brief overview of the history of arbovirus epidemics in the Indian Ocean in XIXth and XXth centuries, a full evaluation of the chikungunya epidemic that occurred in 2005-2006 is provided including both lessons learned and future perspectives. On the positive side, the epidemic has allowed improvement of clinical and pathophysiological knowledge, epidemiological surveillance, vector control, awareness of entomology, avenues for research, and understanding of economic and societal repercussions. On the negative side, the epidemic revealed the limitations of a health care system in an island setting, need for an effective sanitary policy, low public-spiritedness, poor diffusion and understanding of public health announcements, endemization of chikungunya virus in the Indian Ocean, absence of vaccine, and global spread of tropical disease. Discussion of perspectives for future arbovirus disease outbreaks in the Indian Ocean is set against the background of climatic change, unequal socioeconomic progress, and high population growth in the Indian Ocean region.
Sterile insect technique (SIT) is a method of disease vector control technique that consists of releasing overwhelming numbers of sterile males. This method provides an environmentally friendly alternative to insecticides. Another advantage of SIT in comparison with other methods is to provide a targeted species-specific approach. In Reunion Island, SIT has been proposed as a basis for developing a viable method of vector control against Aedes albopictus and Anopheles arabiensis. The technique has already been successfully tested on fly and mosquito species for more than 40 years. The CRVOI (Centre de Recherche et de Veille sur les Maladies Emergentes dans l'Océan Indien) is carrying out studies to determine the feasibility of SIT for control of Anopheles arabiensis (vector of malaria) and Aedes albopictus (vector of chikungunya and dengue) on Reunion Island and other islands in the Indian Ocean region.
The outbreak of chikungunya that occurred on French Island territories in the southwest Indian Ocean in 2005 and 2006 caused severe morbidity and mortality. In the aftermath, French authorities set up a scientific task force including experts in epidemiology, public health, entomology, virology, immunology, sociology, animal health, community and hospital medicine. The mission of the task force was to conceive and propose research programs needed to increase understanding of the disease and epidemic and to help public health officials in improving epidemic response measures. The purpose of this article is to describe the findings of the task force at the end of its two-year existence and initial outcomes in the the areas studied. Discussion emphasizes topics requiring further study.
The chikungunya virus epidemic that occurred on Reunion Island from May 2005 to the end of 2006 affected 30% of the population (more than 250 000 people). As a result of its major clinical impact, this outbreak allowed better documentation of the acute phase of the disease. The disease generally has a slowly self-limiting course over a period of several months with rheumatic manifestations. For practitioners, these symptoms raise numerous questions at several levels, i.e., i) role of the virus in pain, ii) most appropriate treatment, and iii) prevention of development of chronic symptoms. This study in two patient cohorts on Reunion Island was carried out in an attempt to improve understanding and management of chronic rheumatic manifestations following chikungunya virus infection. Findings in 360 patients presenting painful manifestations following chikungunya virus infection showed that the risk of developing inflammatory polyarthritis was higher if the initial acute phase lasted longer than 3 weeks. Based on this observation, it is recommended that these patients undergo rheumatologic evaluation at 3 months to assess the need for possible immunosuppressor treatment (methotrexate).
Chikungunya virus is an arbovirus (alphavirus) transmitted by Aedes albopictus in Reunion Island. A huge chikungunya outbreak swept Reunion Island in 2005- 2006. We report the first case of chikungunya neonatal infection and the 5-years outcome of the 18 neonates hospitalized in neonatal intensive care unit between June 2005 and March 2006.
The chikungunya epidemic that occurred on Reunion Island between 2005 and 2006 was covered by the French health insurance system. This coverage involved a major increase in the number of paid sick leave days and prescription drug refunds in the first quarter of 2006. Special governmental measures such as full reimbursement of certain medications and waiving of the waiting period for sick leave in case of relapse greatly reduced the impact of the epidemic. Five years after, the database of the health insurance systems indicates a low incidence of chronic forms. Only cases managed on an outpatient basis were included in this study.
The purpose of this article is to describe the legal framework for controlling mosquito vectors of diseases transmissible to human beings in certain locations such as Reunion Island. A distinction is made between general legal measures for insect vector control and specific measures for mosquito control. Regionalization is a major factor in the legal framework for insect vector control, thus limiting the scope of action by the prefecture. Another factor involves the increasing role of an important new player, i.e., the regional health agencies. Mosquito vector control raises the need to impose and enforce measures on the general public as well as private citizens. Failure to comply with these measures is punishable by sanctions and fines with no diminishing effect on de jure implementation of control measures by public agencies.
: In 2005-2006 the Chikungunya caused a major sanitary crisis in Reunion for which neither the authorities, nor the healthcare professionals were prepared, as the symptoms were poorly defined, the treatment not validated and the sequels underestimated. General practioners described "in vivo" clinical and therapeutic facts and help conducted three ground studies. They were indeed the doctors of first recourse for painful and feverish patients. Have we drawn all lessons of this sanitary crisis that struck nearly the third of the population? Are we better prepared to face the acute and the chronic forms of a forthcoming epidemic? Efforts and indisputable institutional progress were made, but "Everything" still remains to be made combining all health professional efforts with a better consideration of the professionals of ground.
Since mid 2005 pediatricians of the Groupe hospitalier Sud Reunion de Saint-Pierre have observed a self-imposed requirement to test for mother-to-child transmission of chikungunya. Sanitary authorities refuse to consider such testing as necessary. The risk of mother-to-child transmission was not mentioned in literature of the time.
During the chikungunya outbreak of 2005 - 2006, the only laboratory facilities available in Mauritius were virus isolation in cell culture tubes and serology. The laboratory was submerged with large numbers of blood samples. Comparative isolation was made in human embryonic lung (HEL) and VERO cells grown in 96-well plate. Culture on HEL cells was found to be more sensitive and presence of cytopathic effect (CPE) was observed earlier than in VERO cells. Out of the 18 300 blood samples inoculated on HEL, 11 165 were positive. This virus isolation method was of great help for the surveillance and control of the vectors. In cases of an outbreak a cheap, rapid and simple method of isolating chikungunya virus is described.
INTRODUCTION:The largest chikungunya epidemic in history hit Reunion Island in 2005/6. At that time, a specific monitoring system was set up. Since the end of the epidemic, this monitoring system has continued to operate and has been enhanced. The main objectives of the system are early detection of any case of chikungunya virus infection and epidemiological monitoring.METHODS:During nonepidemic periods, surveillance is focused on active detection of all cases. During epidemic periods, weekly incidence is estimated using data collected via a sentinel physician network. Occurrence of severe and fatal forms is tracked during all epidemiologic situations.RESULTS:In 2005-2006, the estimated number of symptomatic chikungunya-virus infections diagnosed on Reunion Island was 266 000, i.e., an attack rate of 34%. A total of 222 severe cases and 44 mother-to-child transmissions were recorded. Since the end of the outbreak, two clusters have been detected in the western region of the island in 2010 and 2011. The second cluster was non-negligible since it involved 164 cases including 112 that were biologically confirmed.CONCLUSION:Based on results recorded from 2005 to 2006, the chikungunya monitoring system appears to have good sensitivity and reactivity. Recent detection of two disease clusters confirms the system's efficacy.
Settlement of medical malpractice claims was radically changed by the Kouchner Law that set up a rapid, effective system of indemnification. Victims can choose between conventional court proceedings and a non-judicial conciliation procedure. Choice between the two processes depends on the circumstances of the case.
The constitutional precautionary principle as applied in laws governing health care at the community level requires rigorous scientific assessment. The goal of this assessment is to provide authorities with sound evidence as a basis for implementing precautionary measures in function of degree of risk and other parameters such as the level of public health protection that is high in the EU. As the political authority, the government can act independently of conclusions issued by scientific commissions provided that the commission's level of expertise meets national and European standards and that research methodology and findings are consistent with scientific data published in the international literature. These requirements were not meet for the chikungunya pandemic that struck France on Reunion Island and Mayotte from 2004 to 2006. This epidemic that was preceded by many outbreaks in Indonesia between 2001 and 2003 began in Africa and then swept across the Indian Ocean to India and Asia. After an overview of the scientific assessment, this article raises arguments supporting possible allegations of gross misgovernance by the state and experts.
BACKGROUND:Persistence of clinical manifestations, especially polyarthralgia and fatigue, is a characteristic feature of chikungunya virus (CHIK-v) infection. The purpose of this study was to measure the impact of prolonged or late-onset manifestations of CHIK-v infection on the self-perceived health of people on Reunion Island.METHODS:This retrospective cohort survey, dubbed TELECHIK survey, was conducted eighteen months after the end of the chikungunya outbreak on a representative random sample from the SEROCHIK population-based survey conducted on Reunion Island. A total of 1094 subjects whose CHIK-v specific IgG antibody status had been documented were interviewed about current symptoms.RESULTS:Analysis of data showed 45% of CHIK+ vs 14% of CHIK- subjects reporting musculoskeletal pain (P < 0.001), 56% vs. 44% reporting fatigue (P = 0.003), 77% vs. 53% reporting cerebral manifestations (P < 0.001), 51% vs. 34% reporting sensorineural impairments (P < 0.001), 18% vs. 13% reporting digestive complaints (P = 0.06), and 38% vs. 32% reporting skin involvement (P = 0.13). The mean delay between infection and interview was two years (range, 15-34 months). Analysis of data after correction for age, gender, body mass index and comorbidity indicated that rheumatic pain, fatigue, cerebral manifestations and sensorineural impairments were more likely in CHIK+ than CHIK- subjects but the likelihood of digestive and skin manifestations was the same.CONCLUSION:With a mean delay of two years after infection, 45% to 77% of CHIK+ subjects reported prolonged or late-onset symptoms attributable to CHIK-v. These results indicate that persistent manifestations of chikungunya infection have a heavy impact on rheumatologic, neurological and sensorineural health.
